| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Belldegrun Arie is a Director at ALLO, with reported holdings spanning 3 companies. Recent filings cover 5 purchases and 0 sales. Those positions are worth an estimated $2.0M at current prices.
Belldegrun Arie's largest disclosed position is in URGN as Director, worth about $2.0M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | ALLO Allogene Therapeutics, Inc. | Director | Buy | 1,724,137 | $2.90 | $4,999,997.30 | New | -25.2% | -63.1% | |
| Jan 12, 2022 | ALLO Allogene Therapeutics, Inc. | Director | Buy | 155,039 | $12.60 | $1,953,491.40 | +387.6% | -31.0% | -43.2% | |
| Jun 4, 2020 | ALLO Allogene Therapeutics, Inc. | Director | Buy | 146,382 | $47.00 | $6,879,954.00 | +8.9% | - | - | |
| Oct 15, 2018 | ALLO Allogene Therapeutics, Inc. | Director, 10% Owner | Buy | 35,000 | $18.00 | $630,000.00 | New | - | - |